Mesenchymal Stem Cells in Cardiology
Ian A White1, Cristina Sanina1, Wayne Balkan1
1Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, 1501 N.W. 10th Avenue, Miami, FL, 33136, USA.
Insights
Mesenchymal stem cells (MSCs) show promise for cardiac repair after heart attacks by secreting factors that reduce damage and potentially differentiating into heart cells. Further research is needed to understand their exact contribution to healing.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Cardiovascular disease (CVD) is the leading cause of global mortality.
- Myocardial infarction (heart attack) affects 1.5 million Americans annually, with high mortality rates.
- Effective cardiac repair strategies are critically needed.
Purpose of the Study:
- To evaluate mesenchymal stem cells (MSCs) as a therapeutic strategy for cardiac repair.
- To investigate the mechanisms by which MSCs promote healing in damaged hearts.
Main Methods:
- Intramyocardial transplantation of MSCs in preclinical models.
- Analysis of MSCs' paracrine factor secretion.
- Assessment of MSC differentiation potential into cardiac cell types.
Main Results:
- MSCs secrete soluble factors that modulate cardiac remodeling, fibrosis, and immune responses.
- MSCs demonstrate potential for differentiation into cardiomyocytes, endothelial cells, and smooth muscle cells.
- The relative contribution of MSC differentiation versus paracrine effects on cardiac repair is under investigation.
Conclusions:
- Intramyocardial MSC transplantation is a promising therapeutic approach for cardiac repair.
- MSCs exert beneficial effects through both paracrine signaling and potential differentiation.
- Further research is essential to elucidate the precise mechanisms driving MSC-mediated cardiac regeneration.
Abstract:
Cardiovascular disease (CVD) accounts for more deaths globally than any other single disease. There are on average 1.5 million episodes of myocardial infarction (heart attack) each year in the United States alone with roughly one-third resulting in death. There is therefore a major need for developing new and effective strategies to promote cardiac repair. Intramyocardial transplantation of mesenchymal stem cells (MSCs) has emerged as a leading contender in the pursuit of clinical intervention and therapy. MSCs are potent mediators of cardiac repair and are therefore an attractive tool in the development of preclinical and clinical trials. MSCs are capable of secreting a large array of soluble factors, which have had demonstrated effects on pathogenic cardiac remolding, fibrosis, immune activation, and cardiac stem cell proliferation within the damaged heart. MSCs are also capable of differentiation into cardiomyocytes, endothelial cells, and vascular smooth muscle cells, although the relative contribution of trilineage differentiation and paracrine effectors on cardiac repair remains the subject of active investigation.
Related Concept Videos
01:19Mesenchymal Stem Cells
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...